{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T13:43:52Z","timestamp":1793195032726,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004054","name":"King Abdulaziz University","doi-asserted-by":"publisher","award":["IFPRC-199-142-2020"],"award-info":[{"award-number":["IFPRC-199-142-2020"]}],"id":[{"id":"10.13039\/501100004054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-12699-8","type":"journal-article","created":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T14:04:14Z","timestamp":1769781854000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Implications of occult hepatitis B infection for blood donor management: a five-year evaluation from Western Saudi Arabia"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8536-6989","authenticated-orcid":false,"given":"Wajnat A.","family":"Tounsi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somaya","family":"Noorsaeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany I.","family":"Almars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona M.","family":"Almramhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Basri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar A.","family":"Basabrain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Rokan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taghreed S.","family":"Almansouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara H.","family":"Mokhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora Y.","family":"Hakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,30]]},"reference":[{"key":"12699_CR1","unstructured":"-World Health Organization. Global Hepatitis Report 2024: Action for access in low- and middle-income countries; World Health Organization: Geneva, Switzerland, 2024; Licence: CC BY-NC-SA 3.0 IGO."},{"key":"12699_CR2","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1016\/j.jhep.2008.07.014","volume":"49","author":"G -Raimondo","year":"2008","unstructured":"-Raimondo G, Pollicino T, Cacciola I, Squadrito G. Statements from the Taormina expert meeting on occult hepatitis B virus infection. J Hepatol. 2008;49:652\u20137.","journal-title":"J Hepatol"},{"key":"12699_CR3","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.3390\/v14071504","volume":"14","author":"C -Saitta","year":"2022","unstructured":"-Saitta C, Pollicino T, Raimondo G. Occult hepatitis B virus infection: an update. Viruses. 2022;14:1504.","journal-title":"Viruses"},{"key":"12699_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.virol.2015.02.031","volume":"479\u2013480","author":"C -Seeger","year":"2015","unstructured":"-Seeger C, Mason WS. Molecular biology of hepatitis B virus infection. Virology. 2015;479\u2013480:672\u201386.","journal-title":"Virology"},{"key":"12699_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1423-0410.2008.01017.x","volume":"94","author":"HW -Reesink","year":"2008","unstructured":"-Reesink HW, Engelfriet CP, Henn G, Mayr WR, Delage G, Bernier F, et al. Occult hepatitis B infection in blood donors. Vox Sang. 2008;94:153\u201366.","journal-title":"Vox Sang"},{"key":"12699_CR6","doi-asserted-by":"publisher","first-page":"600","DOI":"10.4254\/wjh.v7.i3.600","volume":"7","author":"D -Seo","year":"2015","unstructured":"-Seo D, Whang D, Song E, Han K. Occult hepatitis B virus infection and blood transfusion. World J Hepatol. 2015;7:600\u20136.","journal-title":"World J Hepatol"},{"key":"12699_CR7","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/vox.12770","volume":"114","author":"S -Fiedler","year":"2019","unstructured":"-Fiedler S, Oberle D, Chudy M, Scheiblauer H, Henseler O, Halbauer J, Heiden M, Funk M. Effectiveness of blood donor screening by HIV, HCV, HBV-NAT assays, as well as HBsAg and anti-HBc immunoassays in Germany (2008\u20132015). Vox Sang. 2019;114:443\u201350.","journal-title":"Vox Sang"},{"key":"12699_CR8","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1111\/j.1537-2995.2012.03909.x","volume":"53","author":"R -Taira","year":"2013","unstructured":"-Taira R, Satake M, Momose S, Hino S, Suzuki Y, Murokawa H, Uchida S, Tadokoro K. Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion. 2013;53:1393\u2013404.","journal-title":"Transfusion"},{"key":"12699_CR9","doi-asserted-by":"publisher","first-page":"244","DOI":"10.4103\/ajprhc.ajprhc_4_25","volume":"17","author":"MA -Aljohani","year":"2025","unstructured":"-Aljohani MA, Alabdallat NG. Significance of HBV NAT and HCV NAT in the detection of HBV infection and HCV infection in seronegative blood donors at regional laboratory and central blood bank in al Madinah, Saudi Arabia. Asian J Pharm Res Health Care. 2025;17:244\u201350.","journal-title":"Asian J Pharm Res Health Care"},{"key":"12699_CR10","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.jhep.2020.05.042","volume":"73","author":"L-Y -Mak","year":"2020","unstructured":"-Mak L-Y, Wong DK-H, Pollicino T, Raimondo G, Hollinger FB, Yuen M-F. Occult hepatitis B infection and hepatocellular carcinoma: Epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020;73:952\u201364.","journal-title":"J Hepatol"},{"key":"12699_CR11","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1136\/gutjnl-2018-316490","volume":"68","author":"D -Candotti","year":"2019","unstructured":"-Candotti D, Assennato SM, Laperche S, Allain J-P, Levicnik-Stezinar S. Multiple HBV transfusion transmissions from undetected occult infections: revising the minimal infectious dose. Gut. 2019;68:313\u201321.","journal-title":"Gut"},{"key":"12699_CR12","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3748\/wjg.v17.i12.1553","volume":"17","author":"S -Oca\u00f1a","year":"2011","unstructured":"-Oca\u00f1a S, Casas ML, Buhigas I, Lled\u00f3 JL. Diagnostic strategy for occult hepatitis B virus infection. World J Gastroenterol. 2011;17:1553\u20137.","journal-title":"World J Gastroenterol"},{"key":"12699_CR13","doi-asserted-by":"publisher","first-page":"e0272920","DOI":"10.1371\/journal.pone.0272920","volume":"17","author":"G -Takuissu","year":"2022","unstructured":"-Takuissu G, Kenmoe S, Atsama M, Okobalemba E, Mbaga D, Ebogo-Belobo J, et al. Global epidemiology of occult hepatitis B virus infections in blood donors: A systematic review and meta-analysis. PLoS ONE. 2022;17:e0272920.","journal-title":"PLoS ONE"},{"key":"12699_CR14","doi-asserted-by":"publisher","first-page":"030006052513874","DOI":"10.1177\/03000605251387447","volume":"53","author":"AF -Alrezaihi","year":"2025","unstructured":"-Alrezaihi AF, Alzamil L, Alshalani A, Alsughayyir J, Alshehri FS, Almuqrin AM. Occult hepatitis B virus infection and its demographic and clinical determinants among blood donors in Saudi arabia: A retrospective cross-sectional study. J Int Med Res. 2025;53:03000605251387447.","journal-title":"J Int Med Res"},{"key":"12699_CR15","doi-asserted-by":"publisher","first-page":"3004","DOI":"10.3390\/diagnostics15233004","volume":"15","author":"WA -Tounsi","year":"2025","unstructured":"-Tounsi WA. Prevalence and implications of occult hepatitis B virus infection among blood donors in Saudi arabia: A systematic review and meta-analysis. Diagnostics. 2025;15:3004.","journal-title":"Diagnostics"},{"key":"12699_CR16","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.3390\/diagnostics15212744","volume":"15","author":"H -Ali","year":"2025","unstructured":"-Ali H, Buenning C, Daghfal D. Advancing HBV diagnostics: the role of ultrasensitive HBsAg testing. Diagnostics. 2025;15:2744.","journal-title":"Diagnostics"},{"key":"12699_CR17","unstructured":"Roche D. Cobas\u00ae HBV: Quantitative Nucleic Acid Test for Use on the cobas\u00ae 5800\/6800\/8800 Systems, Instructions for Use; Document 09198946001-05EN. Doc Rev. 4.0; Roche Diagnostics: Mannheim, Germany, 2025. Latest accessed 2025."},{"key":"12699_CR18","doi-asserted-by":"publisher","first-page":"116753","DOI":"10.1016\/j.diagmicrobio.2025.116753","volume":"112","author":"E -Vo-Quang","year":"2025","unstructured":"-Vo-Quang E, Rosse D, Ortonne V, Garrigou O, Ingiliz P, Leroy V, Pawlotsky J-M, Chevaliez S. Performance of the Cobas 5800 system for hepatitis B virus DNA and hepatitis C virus RNA quantification. Diagn Microbiol Infect Dis. 2025;112:116753.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"12699_CR19","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1007\/s44197-022-00051-7","volume":"12","author":"AA -Mobarki","year":"2022","unstructured":"-Mobarki AA, Madkhali MM, Dobie G, Saboor M, Madkhali AM, Madkhli B, Hummadi Y, Meshi A, Al-Mekhlafi HM, Akhter MS, Hamali HA. Patterns of hepatitis B, hepatitis C and HIV among blood donors in Samtah\u2013Jazan region. J Epidemiol Glob Health. 2022;12:304\u201310.","journal-title":"J Epidemiol Glob Health"},{"key":"12699_CR20","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.15537\/smj.2016.10.14705","volume":"37","author":"A -Alshayea","year":"2016","unstructured":"-Alshayea A, Eid G, El-Hazmi M, Alhetheel A. Prevalence and characterization of occult hepatitis B infection among blood donors in central Saudi Arabia. Saudi Med J. 2016;37:1114\u20139.","journal-title":"Saudi Med J"},{"key":"12699_CR21","first-page":"274","volume":"52","author":"MY -Alshahrani","year":"2021","unstructured":"-Alshahrani MY, Alamri AM, Alshahrani AS, Alshehri AA, Alsulaiman AS, Alshahrani AJ, Dabaan MA, Aldhbaan ST, Moosa RA, Alkahtani AM, Chandramoorthy HC. Prevalence of selected blood-borne infectious diseases among voluntary blood donors in Abha, Saudi Arabia. Southeast Asian J Trop Med Public Health. 2021;52:274\u201384.","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"12699_CR22","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.3390\/diagnostics15172261","volume":"15","author":"W -Tounsi","year":"2025","unstructured":"-Tounsi W, Hakami N, Alamoudi S, Altayeb W, Aljuhani S, Al-Sulami A, et al. The grey zone in blood donor screening: A retrospective study and proposal for donor re-entry. Diagnostics. 2025;15:2261.","journal-title":"Diagnostics"},{"key":"12699_CR23","doi-asserted-by":"publisher","first-page":"e101722","DOI":"10.5812\/hepatmon.101722","volume":"20","author":"MRH -Hedayati-Moghaddam","year":"2020","unstructured":"-Hedayati-Moghaddam MRH, Soltanian HS, Behzadifar MB. Occult hepatitis B virus infection prevalence among different populations of iran: A systematic review and meta-analysis. Hepat Mon. 2020;20:e101722.","journal-title":"Hepat Mon"},{"key":"12699_CR24","unstructured":"Food and Drug Administration. Requalification method for reentry of blood donors deferred because of reactive test results for antibody to hepatitis b core antigen (anti-hbc); u.s. food and drug administration, center for biologics evaluation and research: Rockville, MD, USA, 2010. Guidance for Industry. Available online: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm (Accessed on 2025)."},{"key":"12699_CR25","doi-asserted-by":"publisher","first-page":"e25805","DOI":"10.1016\/j.heliyon.2024.e25805","volume":"10","author":"S -Athalye","year":"2024","unstructured":"-Athalye S, Patil A, Khargekar N, Shinde S, Chavan S, Dixit A, Shankarkumar A, Madkaikar M, Banerjee A. Efficacy of combined HBsAg, anti-HBc and anti-HBs screening in minimizing transfusion transmission risk of hepatitis B infection in low-resource settings. Heliyon. 2024;10:e25805.","journal-title":"Heliyon"},{"key":"12699_CR26","first-page":"455","volume":"9","author":"C -Velati","year":"2011","unstructured":"-Velati C, Fomiatti L, Baruffi L, Piccinini V, Prati D, Reina A, Lobbiani A, Zanetti A, Roman\u00f2 L. Criteria for hepatitis B virus screening and validation of blood components in italy: the position of the SIMTI HBV working group. Blood Transfus. 2011;9:455\u201361.","journal-title":"Blood Transfus"},{"key":"12699_CR27","doi-asserted-by":"publisher","first-page":"103095","DOI":"10.1016\/j.eclinm.2025.103095","volume":"81","author":"MX Fu","year":"2024","unstructured":"Fu MX, Elsharkawy A, Healy B, Jackson C, Bradshaw D, Watkins E, Ushiro-Lumb I, Griffiths J, Neuberger J, Maguire K, Desai M, McDougall N, Priddee N, Barclay ST, Blackmore S, Simmonds P, Irving WL, Harvala H. Occult hepatitis B virus infection: risk for a blood supply, but how about individuals\u2019 health? eClinicalMedicine. 2024;81:103095.","journal-title":"eClinicalMedicine"},{"key":"12699_CR28","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/vox.13608","volume":"119","author":"MX -Fu","year":"2024","unstructured":"Fu MX, Ingram J, Roberts C, Nurmi V, Watkins E, Dempsey N, Golubchik T, Breuer J, Brailsford S, Irving WL, Andersson M, Simmonds P, Harvala H. Blood donation screening for hepatitis B virus core antibodies: the importance of confirmatory testing and initial implication for rare blood donor groups. Vox Sang. 2024;119:447\u201359.","journal-title":"Vox Sang"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-12699-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12699-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-12699-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T23:04:42Z","timestamp":1771974282000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-12699-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,30]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["12699"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-12699-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,30]]},"assertion":[{"value":"3 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Research Ethics Committee of King Fahad Armed Forces Hospital, Jeddah, Saudi Arabia, and conducted in accordance with the Declaration of Helsinki. The requirement for donor informed consent was waived due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}